A 2019 systematic review to assess the evidence of craniosacral therapy (CST) for the treatment of chronic pain searching Pubmed, Central, Scopus, PyscInfo, and Cinahl up to August 2018. Results suggest: “Ten RCTs of 681 patients with neck and back pain, migraine, headache, fibromyalgia, epicondylitis, and pelvic girdle pain were included. CST showed greater post intervention effects on: pain intensity (SMD = -0.32, 95%CI = [- 0.61,-0.02]) and disability (SMD = -0.58, 95%CI = [- 0.92,-0.24]) compared to treatment as usual; on pain intensity (SMD = -0.63, 95%CI = [- 0.90,-0.37]) and disability (SMD = -0.54, 95%CI = [- 0.81,-0.28]) compared to manual/non-manual sham; and on pain intensity (SMD = -0.53, 95%CI = [- 0.89,-0.16]) and disability (SMD = -0.58, 95%CI = [- 0.95,-0.21]) compared to active manual treatments. At six months, CST showed greater effects on pain intensity (SMD = -0.59, 95%CI = [- 0.99,-0.19]) and disability (SMD = -0.53, 95%CI = [- 0.87,-0.19]) versus sham. Secondary outcomes were all significantly more improved in CST patients than in other groups, except for six-month mental quality of life versus sham. Sensitivity analyses revealed robust effects of CST against most risk of bias domains. Five of the 10 RCTs reported safety data. No serious adverse events occurred. Minor adverse events were equally distributed between the groups … In patients with chronic pain, this meta-analysis suggests significant and robust effects of CST on pain and function lasting up to six months.”
References:
Research: Haller H, Lauche R, Sundberg T, Dobos G, Cramer H. “Craniosacral therapy for chronic pain: a systematic review and meta-analysis of randomized controlled trials.” BMC Musculoskelet Disord. 2019 Dec 31;21(1):1. Image: Photo by Road Trip with Raj on Unsplash